Clinical trial
Pegfilgrastim Administered on the Same Day as Chemotherapy in Non-Hodgkin's…
NCT00115193 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00115193 |
|---|---|
| Title | Pegfilgrastim Administered on the Same Day as Chemotherapy in Non-Hodgkin's Lymphoma |
| Official title | A Multicenter, Double-Blind, Randomized Study of Pegfilgrastim Administered on the Same Day or the Next Day of R-Chop Chemotherapy in Subjects With Non-Hodgkin's Lymphoma |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non-Hodgkin's Lymphoma |
| Intervention type | Drug |
| Interventions | pegfilgrastim |
| Enrollment | 77 |
| Start date | Feb 1, 2003 |
| Primary completion | Aug 1, 2005 |
| Completion | Aug 1, 2005 |
| First posted | Jun 22, 2005 |
| Last update posted | Aug 29, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: